|
|||||
|
|
A device with human intestine tissue and cells will be launched into space to test effects of weightlessness on immune functions and bacterial infections in the gastrointestinal tract. . . . → Read More: Chip Device to Test Gut Infections on Space Station  Comments are closed  Finance, Joint ventures/collaborations  biomedical, engineering, grant, life sciences, medical device, NIH, physical sciences, space, university 
A computer science and engineering team in Texas is developing a technical solution for virtual reality experiences that can make some users physically ill, with symptoms like seasickness. . . . → Read More: Virtual Reality Illness Fix in Development Comments are closed Finance, New products biomedical, computer science, engineering, grant, life sciences, mathematics, physical sciences, semiconductors, software, university 
A start-up company developing nanoscale particles to deliver gene-editing enzymes, including those for Crispr, is raising $8.5 million in its seed funding round. . . . → Read More: Nanotech Gene Therapy Company Raises $8.5M in Seed Funds Comments are closed Finance, New products Asia, biomedical, biotechnology, engineering, entrepreneurs, equity, genomics, investment, life sciences, materials science, nanotechnology, pharmaceuticals, physical sciences, university 
Moderna Therapeutics, a biotechnology enterprise developing therapies with synthetic RNA, issued its initial public stock offering, or IPO, on Thursday, raising more than $604 million. . . . → Read More: RNA Biotech Raises $604M in IPO One comment - (Comments are closed) Finance biomedical, biotechnology, equity, genomics, investment, IPO, life sciences, pharmaceuticals 
An affiliate of drug maker Janssen Pharmaceutical is licensing a synthetic antibody to treat blood-related cancers from a developer of antibodies based on the immune system of llamas. . . . → Read More: Janssen Licensing Cancer Antibodies in $1.8B Deal Comments are closed Finance, Intellectual property biomedical, biotechnology, cancer, clinical trials, equity, Europe, investment, licensing, life sciences, pharmaceuticals, stem cells 
A new research initiative in the U.K. is collecting and mapping precise combinations of therapies that invoke the immune system to treat lung cancer. . . . → Read More: Project to Catalog Precision Lung Cancer Immunotherapies 5 comments - (Comments are closed) Finance, Joint ventures/collaborations biomedical, cancer, clinical trials, Europe, genomics, grant, life sciences, mathematics, pharmaceuticals, U.K. 
Researchers in the U.K. are developing computer models of heart functions that enable physicians to simulate recommended treatments for individual patients to gauge and optimize their outcomes. . . . → Read More: Personalized Computer Models Developed for Heart Disease 2 comments - (Comments are closed) Finance, New products biomedical, engineering, Europe, grant, heart disease, life sciences, mathematics, medical device, physical sciences, U.K., university 
A bioengineering lab at University of Arizona is researching new techniques with three-dimensional printing, stem cells, and sensors to repair severe bone fractures. . . . → Read More: 3-D Printed Scaffolds with Stem Cells, Sensors Studied to Repair Bones One comment - (Comments are closed) Finance, New products biomedical, DoD, engineering, grant, life sciences, materials science, medical device, pharmaceuticals, physical sciences, physics, preclinical, stem cells, university 
A new federal grant supports expansion of a research and development center developing techniques to make the manufacture and integration of microfluidic, or lab-on-a-chip, devices easier and less expensive. . . . → Read More: NSF Supports Expanding Lab-On-Chip Integration, Manufacturing Center One comment - (Comments are closed) Finance biomedical, engineering, grant, life sciences, manufacturing, medical device, NSF, stem cells, university 
A company spun-off from a university biochemistry lab is raising $30 million to fund discovery of treatments targeting RNA, genetic material instructing protein production in cells. . . . → Read More: RNA Therapeutics Company Raises $30M in First Venture Round One comment - (Comments are closed) Finance, New products biomedical, biotechnology, chemistry, entrepreneurs, equity, Europe, genomics, investment, life sciences, pharmaceuticals, physical sciences, university, venture capital |
||||
|
Copyright © 2019 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
